Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. PETS
stocks logo

PETS

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2026Q2
FY2026Q3
51.10M
-23.16%
-0.070
-138.89%
69.31M
+2%
0.040
-63.64%
60.76M
+2%
-0.060
+100%
Estimates Revision
The market is revising Downward the revenue expectations for PetMed Express, Inc. (PETS) for FY2026, with the revenue forecasts being adjusted by -7.93% over the past three months. During the same period, the stock price has changed by -43.28%.
Revenue Estimates for FY2026
Revise Downward
down Image
-7.93%
In Past 3 Month
EPS Estimates for FY2026
Revise Upward
up Image
+83.33%
In Past 3 Month
Stock Price
Go Down
down Image
-43.28%
In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Petmed Express Inc (PETS.O) is -7.86, compared to its 5-year average forward P/E of -8.40. For a more detailed relative valuation and DCF analysis to assess Petmed Express Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-8.40
Current PE
-7.86
Overvalued PE
99.18
Undervalued PE
-115.99

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
10.53
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
16.02
Undervalued EV/EBITDA
5.05

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.09
Current PS
0.00
Overvalued PS
1.81
Undervalued PS
0.36
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders areBuying! The selling amount has increased 174.01% over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders areBuying! The selling amount has increased 174.01% over the last month.
Sold
Bought
Financial AI Agent
Financial AI Agent

PETS News & Events

Events Timeline

(ET)
2025-11-13
08:08:22
PetMed Express announces estimated Q2 revenue between $43.4M and $44.5M
select
2025-10-20 (ET)
2025-10-20
08:41:51
James LaCamp Joins PetMed Express Board of Directors
select
2025-08-12 (ET)
2025-08-12
16:50:50
PetMed Express CEO Sandra Campos, CFO Robyn D'Elia resign
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
7.0
11-29PRnewswire
PetMed Express Faces Investigation, Stock Plummets 32.41%
  • Investigation Launched: Edelson Lechtzin LLP is investigating potential violations of federal securities laws by PetMed Express, involving allegations of misleading business information to investors, which could significantly impact the company's reputation and investor confidence.
  • Delayed Financial Reports: On June 10, 2025, PetMed announced a delay in releasing its Q4 and full-year financial results, resulting in an 11.22% stock drop to $3.72 on June 11, indicating market concerns over the company's transparency.
  • Impact of Internal Review: On July 1, 2025, PetMed stated it would not file its FY 2025 Annual Report on time due to an internal review of revenue recognition, causing a further 1.51% decline in stock price to $3.27, reflecting investor doubts about the company's financial health.
  • Consequences of Audit Committee Investigation: On November 12, 2025, PetMed reported it could not timely submit its Q3 2025 Form 10-Q due to ongoing Audit Committee investigations, leading to a dramatic 32.41% drop in stock price to $1.96, severely damaging the company's market image and investor trust.
[object Object]
Preview
9.0
11-27Newsfilter
PetMed Express Extends Shareholder Rights Plan Expiration to 2026
  • Rights Plan Extension: PetMed Express's Board unanimously approved extending the expiration date of its existing shareholder rights plan to December 2, 2026, aimed at protecting shareholder investments amid significant stock accumulations by certain shareholders.
  • Shareholder Protection: The continuation of the plan reflects the Board's concerns that the company's shares do not reflect their inherent value, ensuring fair treatment for all shareholders in potential takeovers, thereby enhancing investor confidence.
  • Preventing Hostile Takeovers: By extending the rights plan, PetMed aims to prevent certain shareholders from gaining control without paying a control premium, ensuring stability and transparency in corporate governance.
  • Future Compliance: The company will file a Form 8-K with the SEC detailing the amendment to the rights plan, ensuring transparency and adherence to compliance requirements, further bolstering market trust.
[object Object]
Preview
7.0
11-20PRnewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

  • Investigation Announcement: Pomerantz LLP is investigating potential securities fraud and unlawful business practices involving PetMed Express, Inc. and its officers/directors, urging affected investors to contact them.

  • Earnings Release Delays: PetMed delayed its fourth quarter and fiscal year 2025 earnings release, leading to a significant drop in its stock price by over 11% following the announcement.

  • Annual Report Filing Issues: The company announced further delays in filing its Annual Report due to an internal investigation into revenue recognition, resulting in another decline in stock price.

  • Quarterly Report Filing Challenges: On November 12, 2025, PetMed disclosed it could not timely file its quarterly report for Q3 2025, causing its stock price to plummet by over 32% the following day.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Petmed Express Inc (PETS) stock price today?

The current price of PETS is 1.73 USD — it has decreased -1.7 % in the last trading day.

arrow icon

What is Petmed Express Inc (PETS)'s business?

PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy. The Company is an online provider of prescription and non-prescription medications, food, supplements, and supplies and has veterinary and pet insurance service partnerships for dogs, cats, and horses. It markets and sells directly to consumers through their Websites, toll-free numbers, and employer benefit partnerships. Its product line contains over 15,000 SKUs of pet medications, health products, foods, and supplies. The Company offers various pet supplies, including beds, crates, stairs and other pet supplies. Its products include Prescription Medications (Rx), Non-Prescription Medications (OTC) and supplies, Pet Foods, Private Label and Holistic Wellness Services. Rx includes heartworm and flea and ticks preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

arrow icon

What is the price predicton of PETS Stock?

Wall Street analysts forecast PETS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PETS is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Petmed Express Inc (PETS)'s revenue for the last quarter?

Petmed Express Inc revenue for the last quarter amounts to 46.47M USD, decreased -21.95 % YoY.

arrow icon

What is Petmed Express Inc (PETS)'s earnings per share (EPS) for the last quarter?

Petmed Express Inc. EPS for the last quarter amounts to -0.56 USD, increased 124.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Petmed Express Inc (PETS)'s fundamentals?

The market is revising Downward the revenue expectations for PetMed Express, Inc. (PETS) for FY2026, with the revenue forecasts being adjusted by -7.93% over the past three months. During the same period, the stock price has changed by -43.28%.
arrow icon

How many employees does Petmed Express Inc (PETS). have?

Petmed Express Inc (PETS) has 173 emplpoyees as of December 05 2025.

arrow icon

What is Petmed Express Inc (PETS) market cap?

Today PETS has the market capitalization of 36.36M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free